5248042026-03-312026-03-315248042026-03-31

Prior Intimation of Board Meeting


AUROBINDO PHARMA LIMITED

General Information

NSE Symbol*AUROPHARMA
Whether Company is SME*No
ISIN*INE406A01037
Type of MeetingBoard Meeting
Details of Committee Meeting or Other Type of Meeting
Type of Intimation*New
Reason for Re-schedule (postpone or prepone) / Cancellation
Proposed Meeting Date06-04-2026
Original Meeting Date
Whether trading window is closed*Yes
Trading Window Closure- Start date01-04-2026
Details of Trading Window Closure End dateFurther, pursuant to our letter dated March 23, 2026, the trading window for dealing in securities of the Company was closed for all its designated persons, connected persons and their immediate relatives with effect from April 01, 2026, and shall remain closed until forty-eight hours after the declaration of the audited financial results of the Company for the financial year ending on March 31, 2026. The trading window shall be deemed to be closed in respect of the aforementioned buyback proposal as well, in accordance with applicable laws
Date of Report31-03-2026

Agenda Details

Agenda* Buyback
Whether results are audited or unaudited
Nature of report standalone or consolidated
Period end Type
Period up to (Month)
Period up to (Year)
Mode of raising Funds
Type of Dividend
Remarks (website dissemination)